REGISTERED
on 24 May 2022
Last Applicant/ Owned by
5358 Irwindale Avenue
Irwindale
CA
91706
Serial Number
88851088 filed on 27th Mar 2020
Registration Number
6733441 registered on 24th May 2022
Correspondent Address
Michael J. Hoisington
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
COVICHECK
diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in virus detection; testing kits comprised of medical diagnostic reagents and assays for testing bodily fluids; testing kits comprised of medical diagnostic reagents and assays that test for the presence of antibodies; all of the foregoing in the field of COVID-19 and Coronavirus
Classification Information
Class [005]
Pharmaceutical Products
diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in virus detection; testing kits comprised of medical diagnostic reagents and assays for testing bodily fluids; testing kits comprised of medical diagnostic reagents and assays that test for the presence of antibodies; all of the foregoing in the field of COVID-19 and Coronavirus
First Use Date in General
09th Sep 2020
First Use Date in Commerce
09th Sep 2020
Mark Details
Serial Number
No 88851088
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 24th May 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 24th May 2022 | REGISTERED-SUPPLEMENTAL REGISTER |
| 11th Apr 2022 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 07th Apr 2022 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
| 30th Mar 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 30th Mar 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 30th Mar 2022 | ASSIGNED TO LIE |
| 29th Mar 2022 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
| 28th Mar 2022 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 28th Mar 2022 | USE AMENDMENT ACCEPTED |